drugset / Trial / NCT00212732

Controlled Study of ONO-8025 (KRP-197) in Patients With Overactive Bladder in Japan

NCT00212732

Phase 3 Completed 750 enrolled Ono Pharmaceutical Co., Ltd.
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to evaluate the efficacy and safety of ONO-8025 (KRP-197) in patients with overactive bladder.

Timeline

Start
2003-10
Primary completion
2006-04
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Imidafenacin Small molecule

Indications